NCT03835637View on ClinicalTrials.gov

Single and Multiple Dose Study of ORIC-101 in Adult Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

March 23, 2018

Primary Completion Date

July 4, 2018

Study Completion Date

July 4, 2018

Conditions
Healthy Volunteers
Interventions
DRUG

ORIC-101

Capsule or oral suspension

Trial Locations (1)

Unknown

Research Center, Nottingham

Sponsors
All Listed Sponsors
lead

ORIC Pharmaceuticals

INDUSTRY